InspireMD (InspireMD) Float Percentage Of Total Shares Outstanding : 72.15% (As of Apr. 27, 2024)

View and export this data going back to 1997. Start your Free Trial

What is InspireMD Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InspireMD's float shares is 16.90 Mil. InspireMD's total shares outstanding is 23.42 Mil. InspireMD's float percentage of total shares outstanding is 72.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InspireMD's Insider Ownership is 92.60%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InspireMD's Institutional Ownership is 0.08%.

InspireMD Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

InspireMD's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	16.90	/	23.42
	=	72.15%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD (InspireMD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (NAS:NSPR) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832

Website

https://www.inspiremd.com

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

Executives

Gary S Roubin	director	4300 ROCKMORE RD JACKSON, WYOMING WY 83001
Patrick Verta	officer: EVP Clinical/Medical Affairs	12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN 55344
Michael Berman	director	735 PALAMAR AVENUE, SUNNYVALE CA 94085
Thomas J Kester	director	C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Paul Stuka	director	C/O OSIRIS PARTNERS, LLC, ONE LIBERTY SQUARE, 5TH FLOOR, BOSTON MA 02109
Andrea Tommasoli	officer: Chief Operating Officer	22, RUE DE LA PLAGE, COLLONGES AU MONT D OR I0 69660
Shane Thomas Gleason	officer: VP Global Marketing	18 NORTHAMPTON PL, COTO DE CAZA CA 92679
Kathryn Arnold	director	1136 CHESTNUT AVE., WILMETTE IL 60091
Marvin Slosman	director, officer: CEO and President	4 MENORAT HAMAOR ST., C/O INSPIREMD, INC., TEL AVIV L3 6744832
Isaac Blech	director	C/O INSPIREMD, INC., 321 COLUMBUS AVENUE, BOSTON MA 02116
Agustin V Gago	officer: EVP, Chief Commercial Officer	256 JERUSALEM AVE, MASSAPEQUA NY 11758
Eric L. Olson	officer: VP of Global Sales Operations	C/O INSPIREMD, INC., 800 BOYLSTON STREET, 16TH FLOOR, BOSTON MA 02199
Campbell Rogers	director	C/O INSPIREMD, INC., 800 BOYLSTON STREET, SUITE 16041, BOSTON MA 02199
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Eyal Weinstein	director	C/O LEOREX LTD., P.O.B. 15067 MATAM, HAIFA L3 31905